Abstract

Basics of Compounding: Standardization of Compounded Medications

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2019 - Volume 23, Number 1

Page(s): 35-44

Download in electronic PDF format for $75
  • Basics of Compounding: Standardization of Compounded Medications Page 1
  • Basics of Compounding: Standardization of Compounded Medications Page 2
  • Basics of Compounding: Standardization of Compounded Medications Page 3
  • Basics of Compounding: Standardization of Compounded Medications Page 4
  • Basics of Compounding: Standardization of Compounded Medications Page 5
  • Basics of Compounding: Standardization of Compounded Medications Page 6
  • Basics of Compounding: Standardization of Compounded Medications Page 7
  • Basics of Compounding: Standardization of Compounded Medications Page 8
  • Basics of Compounding: Standardization of Compounded Medications Page 9
  • Basics of Compounding: Standardization of Compounded Medications Page 10

Abstract

The feasibility of standardizing concentrations of compounded drug preparations to attempt to minimize adverse events of both nonsterile and sterile compounded preparations has been discussed. It is critical that a wide variety of opinions and potential “unintended consequences” be aired in the public before an issue like this is recommended to become a standard. In this article, we combine the thoughts and recommendations of many practicing compounding pharmacists from both community and hospital practice sites that have contributed to this topic through the International Journal of Pharmaceutical Compounding’s Compounders’ Network List, a complimentary listserve for our subscribers to share information; ask questions; and provide answers, comments, and opinions. We discuss the advantages, disadvantages, and unintended consequences of standardized concentrations and provide input from numerous practitioners who are “on the front lines” daily.

Related Keywords

  • standardization of compounded preparations
  • standardized drug concentrations
  • parenteral drugs
  • intravenous drug admixtures
  • nonsterile pediatric drugs
  • drug safety
  • children
  • quality assurance
  • medication errors
  • hospital pharmacy
  • Compounders Network List

Related Categories

  • LEGAL
  • PARENTERALS
  • PEDIATRICS
  • QUALITY CONTROL
  • ADVERSE DRUG EVENTS
  • HOSPITAL PHARMACY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2019
Pg. 35-44
Basics of Compounding: Standardization of Compounded Medications
Author(s): Allen Loyd V Jr
Jan/Feb 2020
Pg. 30-36
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Author(s): Dillon L R
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Sep/Oct 2017
Pg. 356
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Author(s): Allen Loyd V Jr
May/Jun 2021
Pg. 222-229
Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation
Author(s): Allen Loyd V Jr
Jan/Feb 2020
Pg. 44-50
Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved
Author(s): Allen Loyd V Jr
Sep/Oct 2018
Pg. 387-398
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Author(s): Ashe Krystina, Baskett Dustin
Sep/Oct 2021
Pg. 396-400
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 11: Drug Tastes: Innate, Induced, and Improved
Author(s): Allen Loyd V Jr
Jul/Aug 2023
Pg. 305-313
Sterile Basics of Compounding: Intravenous Admixture Compounding, Part 3: Preparation Procedures
Author(s): Allen Loyd V Jr
Mar/Apr 2021
Pg. 131-139
Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation
Author(s): Allen Loyd V Jr
Nov/Dec 2012
Pg. 456-460
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis
Author(s): Lyon Joanna
Jan/Feb 2014
Pg. 6-12
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Author(s): Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
Nov/Dec 2011
Pg. 526-527
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse
Author(s): Williams LaVonn A
Mar/Apr 2023
Pg. 123-139
Sterile Basics: Intravenous Admixture Compounding, Part 1: Introduction and Overview of the General Guidelines for an Intravenous Admixture Compounding Program, and Compounding Personnel Considerations
Author(s): Allen Loyd V Jr
Sep/Oct 2014
Pg. 358-364
Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy
Author(s): Palma Elisabetta, Bufarini Celestino
May/Jun 2016
Pg. 202-206
Does Your Drug Expertise Include Clinical Pharmaceutics?
Author(s): Newton David W
Jul/Aug 2016
Pg. 351
View Sample
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 358-362
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA
Author(s): Cabaleiro Joe
Jul/Aug 2022
Pg. 298-301
The Role of Compounding Pharmacists During Drug Shortages
Author(s): Ofei Kelvin
Sep/Oct 2014
Pg. 379-380
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A
Author(s): Blankenship Cynthia E